|
ABCF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.806800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.989500E-02 |
| Normal-vs-Stage2 |
2.270800E-01 |
| Normal-vs-Stage3 |
1.638040E-01 |
| Normal-vs-Stage4 |
3.129200E-01 |
| Stage1-vs-Stage2 |
6.329000E-01 |
| Stage1-vs-Stage3 |
8.148800E-01 |
| Stage1-vs-Stage4 |
7.710800E-01 |
| Stage2-vs-Stage3 |
8.324000E-01 |
| Stage2-vs-Stage4 |
9.551800E-01 |
| Stage3-vs-Stage4 |
9.035000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.060500E-03 |
| Normal-vs-AfricanAmerican |
5.511900E-02 |
| Normal-vs-Asian |
9.061000E-01 |
| Caucasian-vs-AfricanAmerican |
5.935200E-01 |
| Caucasian-vs-Asian |
3.826600E-01 |
| AfricanAmerican-vs-Asian |
4.234400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.541000E-03 |
| Normal-vs-Female |
1.277970E-03 |
| Male-vs-Female |
2.802000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.624000E-01 |
| Normal-vs-Extreme_Weight |
4.262300E-02 |
| Normal-vs-Obese |
3.764300E-03 |
| Normal-vs-Extreme_Obese |
6.875800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.459000E-01 |
| Normal_Weight-vs-Obese |
1.959420E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.957400E-01 |
| Extreme_Weight-vs-Obese |
4.289000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.404200E-01 |
| Obese-vs-Extreme_Obese |
4.487600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.579100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.626900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.068000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.500600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.826420E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.369700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.194100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.394200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.897160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.694400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.09429999997734E-06 |
| Normal-VS-Type2 PRCC |
6.878000E-01 |
| Normal-VS-KIRP CIMP |
1.503200E-01 |
| Normal-VS-Unclassified PRCC |
7.544400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.596000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.773000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.902800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.488000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.651000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.165200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.920400E-01 |
| Normal-vs-N1 |
8.760200E-02 |
| Normal-vs-N2 |
4.227600E-01 |
| N0-vs-N1 |
6.728400E-02 |
| N0-vs-N2 |
4.014200E-01 |
| N1-vs-N2 |
9.156600E-01 |
|
|
